In their recently published study, Illán-Gala et al. (2021) measured plasma NFL in a large cohort of FTD patients (n = 167, including CBS and PSP), of whom 70 had neuropathological confirmation. This evidence concerns the gene NEFL and supranuclear palsy, progressive, 1.